The intelligence agencies of the United States are always paying attention to He Jiang's physical condition.
But after He Jiang was sent to Changzezhou, the intelligence department lost the source of the information.
Because Changzezhou is an isolated delta area, it is not in a big city, and there are no public facilities around it. In addition, Changtian Technology's security measures are very good, so it is difficult for intelligence agencies to penetrate.
Therefore, He Jiang's physical condition is now a mystery.
However, according to the information obtained earlier by the intelligence department, especially the information obtained from 606 tertiary hospitals.
He Jiang is in the middle and late stages of small cell lung cancer.
According to the judgment of the intelligence agency, 100% of patients with mid-to-late stage small cell lung cancer have already started spreading cancer cells.
A lifespan of three to five months is already quite good.
In addition, the He family does not have access to the most advanced targeted drug for small cell lung cancer - osimertinib, which is undergoing clinical trials.
Therefore, relevant medical personnel in the United States judged that He Jiang was likely to die in Changzezhou within a few months.
Therefore, the American medical community sent personnel, on the one hand, to continue to lurk in Suzhou and Hangzhou, Xiaguo, to keep an eye on He Jiang's physical condition; on the other hand, they arranged for people to go to AstraZeneca and the American medical department to ban Oxitizumab.
Ni and other targeted drugs for small cell lung cancer have been exported to achieve results.
In addition to osimertinib, there are a variety of targeted drugs for small cell lung cancer in the United States, but they are not as effective as osimertinib and are not very effective in the treatment of intermediate and advanced small cell lung cancer.
But in order to make He Jiang die as soon as possible, the American medical industry hopes that any pharmaceutical company and pharmaceutical manufacturer will ban the export of any targeted drugs to Xia Guo.
It doesn't matter to the American medical industry whether other cancer patients in Xia State die or not. What they want is for He Jiang to die as soon as possible.
Therefore, in order to make He Jiang die as soon as possible, the U.S. medical industry can immediately cut off the supply of cancer-targeted drugs to Xia Guo.
Moreover, the United States and Xia Guo have no such cooperation in the field of medicine. Currently, all the cancer-targeted drugs exported by the United States to Xia Guo are not commercial activities, but private activities.
Many methods are still informal.
It is very simple to cut off the supply path, and there are no legal or commercial risks.
AstraZeneca is one of the largest pharmaceutical companies in the United States. It must first meet the needs of American consumers, and of course it will listen to the words of relevant American departments and capital.
Therefore, after the intelligence agency issued the warning, AstraZeneca immediately stopped exporting various anti-cancer targeted drugs to Xia Guo.
Osimertinib, which is undergoing clinical trials in the laboratory, has also stopped recruiting volunteers for clinical trials from Chinese people in China or the United States.
In the United States, there is a very cumbersome process for an emerging drug from research and development to final marketing.
The most critical link is clinical trials.
Americans feel that their names are very precious, so the subjects of clinical trials are basically not Americans.
Clinical trialists, even in the United States, are those patients who are terminally ill and have no treatment options and want to try new drugs.
Most of the experimenters are from Asia and Africa, such as Xia Kingdom, India, and Southeast Asian countries.
These people may not be able to find suitable jobs after coming to the United States and are in urgent need of money, or they may not have received a green card from the United States and are illegal immigrants.
By serving as test subjects for this very dangerous experiment, they can gain a certain amount of money or a chance to survive in the United States.
After receiving warnings from the intelligence agencies, all Chinese clinical trial participants were excluded from AstraZeneca.
Xia Guohu Cancer Hospital, Fudan University Hospital.
The hospital has been in contact with AstraZeneca, hoping to introduce osimertinib from AstraZeneca.
The hospital has always had a good cooperative relationship with AstraZeneca. When many of AstraZeneca's new drugs are used in Asia, the Cancer Hospital is also one of the first hospitals to use them.
This time the cancer hospital hopes to introduce osimertinib, and its purpose is to find ways to treat He Jiang.
Everyone knows that there is no way to completely cure late-stage small cell lung cancer.
However, if He Jiang's life can be extended through the latest targeted drugs, He Jiang can have a higher quality of life and more energy to complete the final research and development work of the turbofan 10 engine, or he can devote himself to selecting a few disciples to carefully
Train them and become your own successors, then the country's purpose will be achieved.
The person who contacted AstraZeneca was Ma Yongkai, the vice president of the cancer hospital.
Ma Yongkai studied abroad in the United States in his early years and was later responsible for the hospital's equipment and medicine.
I have to admit that in this era, Xia State's medical technology and equipment were particularly backward. Even the most advanced Fudan University Affiliated Hospital has a large technical gap with overseas medical centers or hospitals.
Ma Yongkai is responsible for connecting with overseas advanced medical equipment companies or pharmaceutical companies, and finding ways to introduce advanced drugs and equipment into hospitals.
Proton therapy equipment was imported from the United States by Ma Yongkai, and it has indeed treated many cancer patients in recent years.
Because Ma Yongkai had strong connections, he immediately contacted AstraZeneca after receiving the order to immediately obtain osimertinib to treat He Jiang.
And also obtained the other party's acquiescence and permission.
The other party hoped that Ma Yongkai could send someone to complete the procedures and get the medicine, and the purpose of getting the medicine was to cooperate with the clinical trials in the United States.
After all, anti-cancer targeted drugs that have not been approved by the FDA are still quite precious and confidential.
Without a legitimate reason and strong connections, it would be impossible for ordinary people to obtain such drugs.
Ma Yongkai also convened a meeting with his subordinates and sent his most trusted team to the United States to get the medicine.
But at this moment, Ma Yongkai received a call from the AstraZeneca contact person.
The other party informed Ma Yongkai that all previously discussed cooperation agreements were invalid. Osimertinib was now prohibited from being sold as an experimental drug. It was impossible to bring osimertinib to Xia Guo by any means.
After receiving such information, Ma Yongkai was shocked.
Obviously both parties have a good discussion. The air tickets here have been bought and they will leave for the United States to get medicines immediately.
If you say cancel now, cancel.
What is the reason?
When Ma Yongkai was about to ask the other party about the specific situation, he didn't know that the other party was silent, saying that it was canceled due to some force majeure.
When something goes wrong, there must be a monster.
Ma Yongkai is not a fool.
Osimertinib clinical trials have lasted for more than half a year.
Previously, Ma Yongkai also obtained related drugs from the United States through various means.
Even some wealthy people in Xia State obtained Osimertinib, which is undergoing clinical trials, through Ma Yongkang's connections.
This shows that even though osimertinib is still in clinical trials, it has begun to be used on a large scale through informal channels.
Since rich people were able to get medicines in the past by spending a little money and having some connections, why can't they get it this time?
Ma Yongkai thought that the other party was asking for a higher price, and through his personal relationship, he found the person in charge of drug sales at AstraZeneca, saying that he could offer a higher price as long as he could get it
Osimertinib.
However, the news that Ma Yongkai received is that AstraZeneca has received a clear request from the U.S. medical industry that many lung cancer targeted drugs, including osimertinib, are not allowed to be sold to Xia Guo.
Those circulating in other places may not be resold to the Xia Kingdom.
This move is quite intimidating.
In particular, the related drugs and some treatment equipment produced by AstraZeneca have a wide range of markets around the world.
If cooperation with the other party is terminated, the partner will suffer heavy losses.
Moreover, the patents of AstraZeneca's equipment and drugs are protected globally. If legal action is taken, companies and even individuals that cooperate with AstraZeneca will face considerable legal risks.
Under such high pressure, no one would take the risk to resell osimertinib to Xia Guo.
After Ma Yongkai got the news, he was very anxious.
He believes that the current situation is beyond his ability to handle.
And just a few months ago, drugs that even wealthy people could buy at high prices through hospitals are now unavailable no matter how hard they try. This shows that the other party has made fundamental changes in their approach to drugs.
Ma Yongkai knew that he would definitely not be able to buy medicine at his level, so he could only report the situation to his superiors immediately.
Yanjing got the root cause of this matter.
That is when the United States learned that He Jiang, the chief designer of the Taihang engine, had small cell lung cancer and was in urgent need of osimertinib, so it terminated the supply.
Not only He Jiang, but also many Xia Guo patients who were waiting for treatment with this drug were temporarily out of stock and were left waiting to die.
After learning the news, Liang Fei, a person in charge of a relevant department, slapped the table angrily and said: "These Americans are waiting for our chief designer to die in his bed!
"
Anger and venting are followed by a period of emptiness and helplessness.
There is no way, because there is a big gap between medical technology and the West. Companies in the United States, such as AstraZeneca and Pfizer, have very strong monopoly power in the medical industry.
It is the freedom of others not to sell you medicine, but there is nothing you can do about it.
What's more, from a nominal point of view, similar to targeted drugs for the treatment of tumors, the two parties have no relevant commercial contacts and trade cooperation. Most of them are black market transactions, and it does not violate laws and ethics if they are not sold.
So there's really nothing you can do.
Seeing Liang Fei getting angry, his subordinates remained silent and did not dare to say anything.
In order to treat He Jiang, Xia Guo cooperated with multiple departments and sent He Jiang to Tianyue Island of Changtian Technology as soon as possible, and asked the Fudan University Affiliated Cancer Hospital to use top-notch equipment and medical staff to fully assist in the treatment.
Thanks to the strong medical technology of Changtian Science and Technology Respiratory Center, He Jiang's condition has been stabilized, but this temporary stability does not mean a complete solution to the problem.
Liang Fei immediately arranged for his subordinates, "You guys go to Mumbai and have a look. AstraZeneca has a corresponding pharmaceutical factory in Mumbai."
The largest natural clinical trial plant of AstraZeneca and other American pharmaceutical companies is in India.
Asan's government also encourages this. After all, India has a caste system, and the lives of lower castes are worthless.
And these poor people are the natural testing ground for American pharmaceutical companies.
One is to use these poor people as test subjects. The price is very cheap. It may take tens or hundreds of meters to complete experiments that would cost tens of millions of dollars to complete in the United States.
Because after these people die, they don’t have to be responsible for compensating any money.
The second is that in the pharmaceutical industry in India, there are not so many cumbersome procedures, and there is no need to consider the probability of mistakes at all. After all, if a mistake is made, the dead will not be held responsible.
Therefore, global pharmaceutical companies, especially those in the United States, particularly like to move clinical laboratories to India.
But it's not free.
India allows you to come and do experiments on the condition that I can imitate your technology without any restrictions and produce related drugs without regard to your patents.
In response to this condition proposed by India, American pharmaceutical companies also turned a blind eye and did not admit it, but they did not completely deny it.
Therefore, India is internationally recognized as a cheap drug store. Many cancer-targeted drugs that cost tens of thousands of dollars per course can be purchased here, and the price is much cheaper than the genuine ones.
Liang Fei was sure that the United States was going to cut off all purchase channels for Osimertinib in Xia, so he did the next best thing and asked his staff to go to India to purchase related drugs.
After all, they could wait, but He Jiang couldn't wait any longer.
Cancer cells grow very quickly.
They are in a race against time.
Liang Fei directly contacted the representative of the state-owned pharmaceutical company in India and asked the relevant staff to go directly to the pharmaceutical factory in Mumbai.
Soon the Mumbai side got the latest news.
All generic drugs of osimertinib have been discontinued, making them unavailable not only to domestic people but also to people in other countries.
It would be strange to say that there is no pressure from the Western world.
Liang Fei was very angry when he got the news.
Liang Fei hated it very much.
Why can’t the domestic pharmaceutical industry break the U.S. monopoly on targeted cancer drugs?
Liang Fei also felt that he was powerless and unable to complete the tasks assigned by the organization.
He and his team could only purchase other first- and second-class targeted drugs at high prices from the black market in the United States and use them to replace osimertinib.
But Liang Fei himself also knew that this type of targeted drug was almost useless for advanced small cell lung cancer.
Liang Fei was forced to report the relevant information to the superior department and Changtian Technology, hoping that Changtian Technology could take some scientific measures.
At this moment, Chen Xiao and Qu Ping are in the VIP ward of the intensive care center.
He Jiang could barely sit up on the bed, but he was wearing a ventilator and would gasp for air after just a few words. His condition was very bad.
Qu Ping received a call, hurriedly walked out, then hurried back, and finally whispered a few words to Chen Xiao.